Severe Cutaneous Adverse Reactions Associated with Immune Checkpoint Inhibitors: A Systematic Review of Clinical Characteristics and Management

被引:0
|
作者
Sood, Siddhartha [1 ]
Bagit, Ahmed [1 ]
Waked, Jihad Abou Ali [2 ]
Perlmutter, Jonah [1 ]
Tarafdar, Nawar [2 ]
Maliyar, Khalad [3 ]
Sachdeva, Muskaan [3 ]
Abduelmula, Abrahim [3 ]
Mufti, Asfandyar [3 ,4 ]
Yeung, Jensen [3 ,4 ,5 ,6 ]
机构
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Univ Western Ontario, Fac Med, London, ON, Canada
[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada
[5] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,5th Floor, Toronto, ON M5S 1B2, Canada
[6] Prob Med Res, Waterloo, ON, Canada
关键词
severe cutaneous adverse reaction; Stevens-Johnson syndrome; toxic epidermal necrolysis; drug reaction with eosinophilia and systemic symptoms; acute generalized exanthematous pustulosis; immune checkpoint inhibitor; systematic review;
D O I
10.1177/12034754251320632
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management
    Astaras, Christophoros
    de Micheli, Rita
    Moura, Bianca
    Hundsberger, Thomas
    Hottinger, Andreas F.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (01)
  • [32] NEUROLOGICAL ADVERSE EVENTS ASSOCIATED WITH THE IMMUNE CHECKPOINT INHIBITORS: REVIEW OF THE LITERATURE AND CHARACTERIZATION OF THE CLINICAL PATTERNS
    Cuzzubbo, Stefania
    Tissier, Mathilde
    Roumi, Arnaud
    Javeri, Florian
    Barlog, Ciprian
    Doridam, Jennifer
    Ursu, Renata
    Belin, Catherine
    Carpentier, Antoine F.
    NEURO-ONCOLOGY, 2016, 18 : 143 - 143
  • [33] Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management
    Christophoros Astaras
    Rita de Micheli
    Bianca Moura
    Thomas Hundsberger
    Andreas F. Hottinger
    Current Neurology and Neuroscience Reports, 2018, 18
  • [34] Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System
    Godfrey, Hannah
    Jedlowski, Patrick
    Thiede, Rebecca
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (03) : 243 - 253
  • [35] Incidence, Clinical Characteristics, and Predictors of Cardiovascular Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
    Isawa, Tsuyoshi
    Toi, Yukihiro
    Sugawara, Shunichi
    Taguri, Masataka
    Toyoda, Shigeru
    ONCOLOGIST, 2022, 27 (05): : E410 - E419
  • [36] Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review
    Shalata, Walid
    Abu-salman, Amjad
    Steckbeck, Rachel
    Mathew Jacob, Binil
    Massalha, Ismaell
    Yakobson, Alexander
    CANCERS, 2021, 13 (20)
  • [37] Cerebellar involvement associated with immune checkpoint inhibitors: A systematic review
    Dinoto, Alessandro
    Mantovani, Elisa
    Ferrari, Sergio
    Mariotto, Sara
    Tamburin, Stefano
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (03) : 774 - 781
  • [38] Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review
    Cozma, Angela
    Sporis, Nicolae Dan
    Lazar, Andrada Luciana
    Buruiana, Andrei
    Ganea, Andreea Maria
    Malinescu, Toma Vlad
    Berechet, Bianca Mihaela
    Fodor, Adriana
    Sitar-Taut, Adela Viviana
    Vlad, Vasile Calin
    Negrean, Vasile
    Orasan, Olga Hilda
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [39] Vasculitis associated with immune checkpoint inhibitors-a systematic review
    Daxini, Anisha
    Cronin, Keri
    Sreih, Antoine G.
    CLINICAL RHEUMATOLOGY, 2018, 37 (09) : 2579 - 2584
  • [40] Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
    Cuzzubbo, S.
    Javeri, F.
    Tissier, M.
    Roumi, A.
    Barlog, C.
    Doridam, J.
    Lebbe, C.
    Belin, C.
    Ursu, R.
    Carpentier, A. F.
    EUROPEAN JOURNAL OF CANCER, 2017, 73 : 1 - 8